Liquidia Corporation Common Stock vs Mongodb Inc — how do they compare? Liquidia Corporation Common Stock trades at $33.66 (market cap $2.40B), while Mongodb Inc trades at $351 (market cap $30.05B). The key difference: Mongodb Inc is far larger — about 12.5× Liquidia Corporation Common Stock's market cap, and Mongodb Inc is trading nearer its 52-week high, Liquidia Corporation Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Liquidia Corporation Common Stock for 0 Days and Mongodb Inc for 46 Days on average.
| LQDA | MDB | |
|---|---|---|
Market Cap | $2.40B | $30.05B |
Volume | 2,857,547 | 3,027,814 |
Sector | Health | Technology |
52-Week High | $91.03 | $472.29 |
52-Week Low | $22.02 | $225.95 |
Typical Hold Time | 0 Days | 46 Days |
Enterprise Value | $2.30B | $27.67B |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
MDB trades at $356.29, down 6.56% over 24 hours, with a bullish technical signal from moving averages but neutral oscillators. The company reported three consecutive quarterly EPS beats, with Q3 2026 results pending. Revenue has grown from $874 million in 2022 to $2.01 billion in 2025, though net losses persist, narrowing to -$129 million in 2025. Recent news highlights AI product launches and a CEO transition, with investor sentiment mixed following a sharp sell-off.
The outlook is cautiously optimistic, with a consensus price target of $456.76 implying 28% upside. Key opportunities include raised long-term revenue targets exceeding 20% growth and AI-driven product expansion. Risks involve continued net losses, high valuation multiples, and execution challenges amid leadership changes. Analyst consensus is strongly bullish with 80% buy ratings, but stock volatility may persist near-term.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Liquidia Corporation is a biopharmaceutical company that develops therapies for rare cardiopulmonary diseases, including YUTREPIA, an inhaled treprostinil powder for pulmonary hypertension built on its PRINT technology.
Read more on LQDA →Founded in 2007, MongoDB is a document-oriented database with nearly 33,000 paying customers and well past 1.5 million free users. MongoDB provides both licenses as well as subscriptions as a service for its NoSQL database. MongoDB's database is compatible with all major programming languages and is capable of being deployed for a variety of use cases.
Read more on MDB →